Highly attenuated β-herpesvirus with potent immunomodulatory capacity as vaccine vector against SARS-CoV-2
Project title: Highly attenuated β-herpesvirus with potent immunomodulatory capacity as vaccine vector against SARS-CoV-2
Grantor: Croatian Science Foundation
Grantor’s website: www.hrzz.hr
Coordinator: Prof. Dr. Astrid Krmpotic
Asst. Prof. Dr. Irena Slavuljica
Dr. Maja Cokaric Brdovcak
Dr. Lea Hirsl
Mijo Golemac, dr. med.
Tina Jenus, mag. biotech. in med.
Marko Sustic, dr. med.
Mihaela Kordun, dipl. ing. mol.
Total funding: EUR 197.200,00
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), appeared in China at the end of 2019 and has rapidly increased into global pandemic and a major public health issue. COVID-19 symptoms can range from very